Skip to content

Vertical and Horizontal Mandibular Ridge Augmentation Techniques

Vertical and Horizontal Mandibular Ridge Augmentation Techniques: A Randomized Controlled Clinical Trial Comparing Customized CAD/CAM Titanium Mesh Versus Reinforced Perforated PTFE Mesh

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06636084
Enrollment
0
Registered
2024-10-10
Start date
2025-12-01
Completion date
2027-06-01
Last updated
2025-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Horizontal Ridge Deficiency, Vertical Ridge Deficiency

Brief summary

The purpose of this study is to compare alveolar ridge augmentation outcomes of two types of membranes for vertical and horizontal mandibular ridge augmentation: Customized CAD/CAM Titanium Mesh versus Reinforced Perforated PTFE Mesh (RPM).

Interventions

A composite graft composed of a 50:50 proportion of autogenous bone and a demineralized bone mineral will be positioned around the bony defect or placed in the membrane, depending on the group randomization. The selected membrane will then be secured with screws to ensure a complete and stable coverage of the grafted area.

Sponsors

University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 years * Physical status according to the American Society of Anesthesiology (ASA) I or II, which includes patients who are systematically healthy or may suffer from mild to moderate, however well-controlled systemic diseases. * Subjects having at least one free end saddle edentulous area of the posterior area of the mandible with moderate horizontal and vertical bone defects \>≥3mm. * Capacity to understand and accept the written conditions of the study.

Exclusion criteria

* Insufficient oral hygiene. * Smoking habit of \>10 cigarettes/day (self-reported). * Abuse of alcohol or drugs. * Pregnancy or individuals attempting to get pregnant (self-reported). * Acute local or systemic infections. * Uncontrolled diabetes or other metabolic disease. * Severe hepatic or renal dysfunction. * Autoimmune disorders. * Patients who underwent radiotherapy in the last 5 years. * Patients undergoing immunosuppressive therapy or who are immunocompromised. * Any other contraindications for undergoing surgery.

Design outcomes

Primary

MeasureTime frameDescription
Ridge width changes in mm6 monthsRadiographic changes of the ridge width based on cone-beam computed tomography (CBCT) scan measurements
Ridge height changes in mm6 monthsRadiographic changes of the ridge width based on cone-beam computed tomography (CBCT) scan measurements

Secondary

MeasureTime frameDescription
The volumetric bone gain of the grafted area in mm36 monthsRadiographic changes of bone volume based on cone-beam computed tomography (CBCT) scan measurements
Change in the mucosal thickness in mm6 monthsChange in the mucosal thickness due to the provided space from baseline to the surgical mesh removal using an ultrasound
Cost analysis6 monthsDifference in cost-effectiveness in dollars
Rate of complications6 monthsPercentage that had complications associated with each technique
Histological outcomes of the augmented bone6 monthsIn terms of the amount of newly formed vital bone, residual graft particles, and connective tissue (CT)/other non-mineralized tissue components as a percentage

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026